Million, M., Giraud-Gatineau, A., Lagier, J., Parola, P., Gautret, P., & Raoult, D. (2021). Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin. Travel Med Infect Dis.
Citação norma ChicagoMillion, Matthieu, Audrey Giraud-Gatineau, Jean-Christophe Lagier, Philippe Parola, Philippe Gautret, e Didier Raoult. "Reply to Lebeaux D, Revest M. No Evidence of Clinical Benefits of Early Treatment of COVID-19 Patients With Hydroxychloroquine and Azithromycin." Travel Med Infect Dis 2021.
Citação norma MLAMillion, Matthieu, et al. "Reply to Lebeaux D, Revest M. No Evidence of Clinical Benefits of Early Treatment of COVID-19 Patients With Hydroxychloroquine and Azithromycin." Travel Med Infect Dis 2021.